Excessive Pricing Causes Poor Access to Biologics

J Rheumatol. 2018 Jun;45(6):876. doi: 10.3899/jrheum.171401.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arthritis, Rheumatoid*
  • Arthroplasty, Replacement*
  • Biological Products*
  • Humans
  • New Zealand
  • Osteoarthritis*

Substances

  • Biological Products